COc1ccc2c(c1)C(=O)[C@H](OC(=O)NCCOc1ccccc1)[C@@H](c1ccc(OC)c(Br)c1)O2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?